Cancer-Associated Pulmonary Embolism (initial anticoagulation)
A 59-year-old man develops progressive dyspnea and hypoxemia 20 hours after laparotomy for colonic adenocarcinoma with liver metastases. Blood pressure is 122/76 mm Hg, heart rate 108 beats/min, respiratory rate 24 breaths/min, oxygen saturation 88% on room air. CT pulmonary angiography shows a right lower lobe embolus. Hemoglobin is 11.2 g/dL. Which of the following is the most appropriate initial treatment?
- A.Warfarin alone
- B.Rivaroxaban
- C.Inferior vena cava filter
- D.EnoxaparinCorrect
Explanation
Low molecular weight heparin such as enoxaparin is the preferred initial anticoagulant for pulmonary embolism in a patient with active malignancy who has just undergone abdominal surgery. It acts immediately by potentiating antithrombin against factor Xa, has predictable pharmacokinetics without routine monitoring, and, crucially, can be stopped with a short half-life if postoperative bleeding develops or reoperation is needed. Malignancy creates a hypercoagulable state through tissue factor expression and cytokine release, and major surgery adds stasis and endothelial injury, so this early postoperative embolus is entirely expected. He is normotensive without right ventricular failure, so this is not high-risk pulmonary embolism and thrombolysis is not indicated. Warfarin cannot be used alone at the outset because it takes days to achieve a therapeutic INR and transiently depletes protein C, producing an early prothrombotic state, so it always requires parenteral bridging. Direct oral anticoagulants such as rivaroxaban are now accepted alternatives in cancer-associated thrombosis, but they are avoided immediately after gastrointestinal surgery and in luminal gastrointestinal malignancy because of a higher bleeding rate, and oral absorption may be unreliable in the early postoperative period. An inferior vena cava filter is reserved for patients in whom anticoagulation is absolutely contraindicated. Anticoagulation for cancer-associated venous thromboembolism continues for at least 6 months and often while the cancer remains active.
Why each option
- A.
- Warfarin has a delayed onset and an early prothrombotic effect from protein C depletion, so it can never be used as sole initial therapy.
- B.
- Rivaroxaban is an option for cancer thrombosis in general but is avoided immediately after gastrointestinal surgery and in luminal gastrointestinal cancer because of bleeding risk.
- C.
- A vena cava filter is only for patients who cannot receive anticoagulation at all; it does not treat the existing clot.
- D.
- Correct. Low molecular weight heparin gives immediate, predictable anticoagulation and is preferred here; protamine reverses its anti-factor Xa effect only incompletely.
Reference: ASH 2021 Guidelines for Management of Venous Thromboembolism in Patients With Cancer
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank